Recruitment of bone marrow-derived endothelial cells to sites of pancreatic β-cell injury

Mathews, V. ; Hanson, P. T. ; Ford, E. ; Fujita, J. ; Polonsky, K. S. ; Graubert, T. A. (2004) Recruitment of bone marrow-derived endothelial cells to sites of pancreatic β-cell injury Diabetes, 53 (1). pp. 91-98. ISSN 0012-1797

Full text not available from this repository.

Official URL:

Related URL:


Endothelial progenitor cells (EPCs) are detectable in the blood and bone marrow throughout life. These cells contribute to new blood vessel formation (neovascularization) in physiological states such as wound healing and in pathological states such as tumor angiogenesis. We hypothesized that bone marrow-derived EPCs could play a role in the response to pancreatic islet cell injury. We used a murine model of experimentally induced β-cell injury followed by transplantation with genetically marked bone marrow cells. Bone marrow-derived cells were detectable throughout the pancreas after transplantation. Whereas the total number of bone marrow-derived cells in the pancreas decreased over time, the frequency of endothelial cells (of both donor and recipient origin) increased after transplantation in the animals in which β-cell injury had been induced. There was no evidence in this model that bone marrow-derived cells differentiated into insulin-expressing cells. This study provides evidence that bone marrow-derived EPCs are recruited to the pancreas in response to islet injury. EPC-mediated neovascularization of the pancreas could in principle be exploited to facilitate the recovery of non-terminally injured β-cells or to improve the survival and/or function of islet allografts.

Item Type:Article
Source:Copyright of this article belongs to American Diabetes Association.
ID Code:113343
Deposited On:07 Jun 2018 12:03
Last Modified:08 Jun 2018 07:57

Repository Staff Only: item control page